Dokumendiregister | Ravimiamet |
Viit | REP-1/1045-1 |
Registreeritud | 28.02.2025 |
Sünkroonitud | 03.03.2025 |
Liik | Sissetulev kiri |
Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
Toimik | REP-1/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Directorate for the Quality of Medicines & HealthCare |
Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
Vastutaja | Signe Leito (RA, Peadirektori asetäitja valdkond, Labor) |
Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: kolmapäev, 26. veebruar 2025 09:52 Adressaat: Signe Leito Teema: Proposed suppression of the monograph on Ouabain 0048 from the Ph. Eur.: EDQM-2025-00946-mail
Please make sure to include in any reply our mail reference: EDQM-2025-00946-mail **************************************************************************** European Pharmacopoeia Commission Secretariat
RZ/PH/ 2025-00943L Aba/mk
Strasbourg, 25 February 2025
LETTER FOR THE ATTENTION OF THE NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed suppression of the monograph on Ouabain (0048) from the work programme of group of experts 11.
Please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=685725&lang=en
Deadline for replies: 13 March 2025
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
Kind regards,
On behalf of Aurélie BARTH
Mireille Kopf Secretarial Assistant European Pharmacopoeia Department EDQM - Council of Europe Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM
**************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2025-00946-mail
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Euroopa farmakopöa asjus | 28.02.2025 | 3 | REP-1/1045-2 | Väljaminev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |